Homozygous EIF2AK3 mutations have been found in WRS patients with age at onset up to 2.5 years [2], in one WRS patient with no bone dysplasia at age 32 years [4], and hepatic failure has not been reported in all WRS patients [3]. This evidence concerns the gene EIF2AK3 and Wolcott-Rallison syndrome.